Received Nov 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | — | — |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | — | — |
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | — | — |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | — | — |
Patient was co-administered two "Hib" vaccines; patient was administered PEDVAX HIB and VAXELIS concomitantly; Patient was co-administered two "Hib" vaccines; patient was administered PEDVAX HIB and VAXELIS concomitantly; This non-serious spontaneous safety report, with reference number 02905156 (Interaction Number 02905155), was received by partner on 12-NOV-2025 and forwarded on 13-NOV-2025 from a nurse. Due to the nature of the event, the causality between the event Patient was co-administered two "Hib" vaccines; patient was administered PEDVAX HIB and VAXELIS concomitantly' and Vaxelis was not applicable. Further information is expected.
Prophylaxis